JNJ-61803534 is a potent and orally active RORgammat inverse agonist with an IC50 of 9.6 nM. JNJ-61803534 has anti-inflammatory activity. JNJ-61803534 inhibits IL-17A production in human CD4+ T cells under Th17 differentiation conditions[1].
Molecular Weight:
622.41
Purity:
99.88
CAS Number:
[1917306-14-9]
Formula:
C23H23Cl2F6N3O4S
Target:
ROR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted